{"api":"v1","generated_at":"2026-10-01T05:55:17.755Z","licence":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/","attribution":"TOLL, with a link to the page cited"},"page":"https://tollindex.com/e/api-magentlab-com-api-calc-ascvd-vhr-859908","pinned_page":"https://tollindex.com/e/api-magentlab-com-api-calc-ascvd-vhr-859908/at/2026-10-01T05-50Z","pinned":false,"method":"https://tollindex.com/ledger/method","snapshot_at":"2026-10-01T05:50:06.230Z","snapshot_stamp":"2026-10-01T05-50Z","endpoint":{"slug":"api-magentlab-com-api-calc-ascvd-vhr-859908","canonical_url":"https://api.magentlab.com/api/calc/ascvd_vhr","resource":"https://api.magentlab.com/api/calc/ascvd_vhr","http_method":"POST","type":"http","x402_version":2,"registries":["cdp"],"primary_registry":"cdp","curated_by_coinbase":false,"description":"AHA/ACC 2018 Table 4 very high-risk ASCVD for known clinical ASCVD. Very high-risk if ≥2 major events (recent ACS, prior MI, ischemic stroke, symptomatic PAD) or 1 major event and ≥2 high-risk conditions (age ≥65, heterozygous FH, CABG/PCI outside those events, diabetes, hypertension, CKD eGFR 15-59, current smoking, LDL-C ≥100 on max statin and ezetimibe, congestive HF). Not PCE. Not a statin, ezetimibe, or PCSK9 order. magent does not diagnose ASCVD or measure ABI or LDL-C.","service_name":"magent","declared_category":null,"declared_tags":["ascvd","very-high-risk","aha-acc-2018","lipids","cholesterol"],"route_template":null,"registry_updated":"2026-09-28T14:21:23.755Z"},"derived":{"note":"fields no registry supplies; TOLL derives them and marks them derived on the page","title":"calc ascvd vhr","category":"other","first_observed_by_toll":"2026-09-28T13:51:25.436Z","last_observed_by_toll":"2026-10-01T05:50:06.230Z","observation_began":"2026-09-10"},"presence":{"listed_now":true,"first_absent_at":null,"delisting_confirmed_at":null,"events":[{"registry":"cdp","at":"2026-09-28T13:51:25.437Z","event":"listed"}]},"accepts":[{"registry":"cdp","ordinal":0,"network":"eip155:8453","asset":"0x833589fcd6edb6e08f4c7c32d4f71b54bda02913","asset_name":"USD Coin","symbol":"USDC","decimals":6,"amount_display":"0.005 USDC","amount_units":0.005,"decimals_known":true,"pay_to":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","scheme":"exact"}],"counters":{"observed_at":"2026-10-01T05:50:06.230Z","calls_30d":2,"unique_payers_30d":1,"last_called_at":"2026-09-28T14:21:23.553Z"},"validation":{"latest":{"observed_at":"2026-09-30T07:41:05.278Z","state":"pass","failed_checks":[],"endpoint_http_status":402,"run_id":"daily-2026-09-30"},"uptime":[{"days":7,"observed":4,"passed":4,"ratio":1},{"days":30,"observed":4,"passed":4,"ratio":1},{"days":90,"observed":4,"passed":4,"ratio":1}],"history_90d":[{"observed_at":"2026-09-30T07:41:05.278Z","state":"pass","failed_checks":[],"run_id":"daily-2026-09-30","state_changed":false},{"observed_at":"2026-09-29T19:54:56.340Z","state":"pass","failed_checks":[],"run_id":"daily-2026-09-29","state_changed":false},{"observed_at":"2026-09-28T16:58:47.038Z","state":"pass","failed_checks":[],"run_id":"daily-2026-09-28","state_changed":false},{"observed_at":"2026-09-28T16:44:45.729Z","state":"pass","failed_checks":[],"run_id":"new-after-daily-2026-09-28","state_changed":true}]},"seller":{"wallet":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","page":"https://tollindex.com/seller/0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","endpoints":844,"hosts":1},"reports":0,"registry_record":{"cdp":[{"tags":["ascvd","very-high-risk","aha-acc-2018","lipids","cholesterol"],"type":"http","accepts":[{"asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"name":"USD Coin","version":"2","paymentFlow":"upfront","resourceUrl":"https://api.magentlab.com/api/calc/ascvd_vhr","assetTransferMethod":"eip3009"},"payTo":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","amount":"5000","scheme":"exact","network":"eip155:8453","maxTimeoutSeconds":600}],"quality":{"lastCalledAt":"2026-09-28T14:21:23.553Z","l30DaysTotalCalls":2,"l30DaysUniquePayers":1},"resource":"https://api.magentlab.com/api/calc/ascvd_vhr","extensions":{"bazaar":{"info":{"input":{"body":{"items":[{"age":70,"diabetes":true,"history_mi":true,"recent_acs":false,"hypertension":false,"congestive_hf":false,"current_smoking":false,"heterozygous_fh":false,"ischemic_stroke":false,"symptomatic_pad":false,"ckd_egfr_15_to_59":false,"prior_cabg_or_pci_outside_major":false,"ldl_c_ge_100_on_max_statin_ezetimibe":false},{"age":70,"diabetes":true,"history_mi":true,"recent_acs":false,"hypertension":false,"congestive_hf":false,"current_smoking":false,"heterozygous_fh":false,"ischemic_stroke":false,"symptomatic_pad":false,"ckd_egfr_15_to_59":false,"prior_cabg_or_pci_outside_major":false,"ldl_c_ge_100_on_max_statin_ezetimibe":false}]},"type":"http","method":"POST"},"output":{"type":"json","example":{"path":"/api/calc/ascvd_vhr","count":2,"items":[{"age":70,"formula":"ascvd_vhr","citation":{"id":"grundy-2018-aha-acc-cholesterol","doi":"10.1161/CIR.0000000000000625","pmid":"30586774","title":"2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol","source":"Circulation. 2019;139(25):e1082-e1143","authors":"Grundy SM, Stone NJ, Bailey AL, et al."},"criteria":[{"met":false,"factor":"recent_acs"},{"met":true,"factor":"history_mi"},{"met":false,"factor":"ischemic_stroke"},{"met":false,"factor":"symptomatic_pad"},{"met":true,"value":70,"factor":"age_ge_65"},{"met":false,"factor":"heterozygous_fh"},{"met":false,"factor":"prior_cabg_or_pci_outside_major"},{"met":true,"factor":"diabetes"},{"met":false,"factor":"hypertension"},{"met":false,"factor":"ckd_egfr_15_to_59"},{"met":false,"factor":"current_smoking"},{"met":false,"factor":"ldl_c_ge_100_on_max_statin_ezetimibe"},{"met":false,"factor":"congestive_hf"}],"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","very_high_risk":true,"classifying_rule":"one_major_and_multiple_high_risk_conditions","major_event_count":1,"formula_expression":"very_high_risk iff major_event_count ≥ 2 or (major_event_count = 1 and high_risk_condition_count ≥ 2) (AHA/ACC 2018 Table 4 / Figure 1). Major events (caller-assigned): recent ACS within 12 months; history of MI other than that recent ACS; history of ischemic stroke; symptomatic PAD (claudication with ABI <0.85, or prior revascularization or amputation). High-risk conditions: age ≥65 years; heterozygous familial hypercholesterolemia; prior CABG or PCI outside the major ASCVD event(s); diabetes mellitus; hypertension; CKD (eGFR 15–59 mL/min/1.73 m²); current smoking; persistently elevated LDL-C ≥100 mg/dL (≥2.6 mmol/L) despite maximally tolerated statin and ezetimibe; history of congestive HF. Not PCE 10-year risk. Not a statin, ezetimibe, or PCSK9 order. magent does not diagnose ASCVD or measure ABI or LDL-C","high_risk_condition_count":2},{"age":70,"formula":"ascvd_vhr","citation":{"id":"grundy-2018-aha-acc-cholesterol","doi":"10.1161/CIR.0000000000000625","pmid":"30586774","title":"2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol","source":"Circulation. 2019;139(25):e1082-e1143","authors":"Grundy SM, Stone NJ, Bailey AL, et al."},"criteria":[{"met":false,"factor":"recent_acs"},{"met":true,"factor":"history_mi"},{"met":false,"factor":"ischemic_stroke"},{"met":false,"factor":"symptomatic_pad"},{"met":true,"value":70,"factor":"age_ge_65"},{"met":false,"factor":"heterozygous_fh"},{"met":false,"factor":"prior_cabg_or_pci_outside_major"},{"met":true,"factor":"diabetes"},{"met":false,"factor":"hypertension"},{"met":false,"factor":"ckd_egfr_15_to_59"},{"met":false,"factor":"current_smoking"},{"met":false,"factor":"ldl_c_ge_100_on_max_statin_ezetimibe"},{"met":false,"factor":"congestive_hf"}],"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","very_high_risk":true,"classifying_rule":"one_major_and_multiple_high_risk_conditions","major_event_count":1,"formula_expression":"very_high_risk iff major_event_count ≥ 2 or (major_event_count = 1 and high_risk_condition_count ≥ 2) (AHA/ACC 2018 Table 4 / Figure 1). Major events (caller-assigned): recent ACS within 12 months; history of MI other than that recent ACS; history of ischemic stroke; symptomatic PAD (claudication with ABI <0.85, or prior revascularization or amputation). High-risk conditions: age ≥65 years; heterozygous familial hypercholesterolemia; prior CABG or PCI outside the major ASCVD event(s); diabetes mellitus; hypertension; CKD (eGFR 15–59 mL/min/1.73 m²); current smoking; persistently elevated LDL-C ≥100 mg/dL (≥2.6 mmol/L) despite maximally tolerated statin and ezetimibe; history of congestive HF. Not PCE 10-year risk. Not a statin, ezetimibe, or PCSK9 order. magent does not diagnose ASCVD or measure ABI or LDL-C","high_risk_condition_count":2}]}},"iconUrl":"https://api.magentlab.com/favicon.ico"},"schema":{"type":"object","$schema":"https://json-schema.org/draft/2020-12/schema","required":["input"],"properties":{"input":{"type":"object","required":["type","method"],"properties":{"body":{"type":"object","required":["items"],"properties":{"items":{"type":"array","items":{"type":"object","required":["age","recent_acs","history_mi","ischemic_stroke","symptomatic_pad","heterozygous_fh","prior_cabg_or_pci_outside_major","diabetes","hypertension","ckd_egfr_15_to_59","current_smoking","ldl_c_ge_100_on_max_statin_ezetimibe","congestive_hf"],"properties":{"age":{"type":"integer","description":"Age in years (18-120). ≥65 is an AHA/ACC 2018 Table 4 high-risk condition. magent does not assign age."},"diabetes":{"type":"boolean","description":"Diabetes mellitus as assigned by the caller (AHA/ACC 2018 Table 4 high-risk condition). true or false. magent does not diagnose diabetes."},"history_mi":{"type":"boolean","description":"History of MI other than a caller-assigned recent ACS as assigned by the caller (AHA/ACC 2018 Table 4 major ASCVD event). true or false. magent does not diagnose MI."},"recent_acs":{"type":"boolean","description":"Recent ACS within the past 12 months as assigned by the caller (AHA/ACC 2018 Table 4 major ASCVD event). true or false. magent does not date ACS."},"hypertension":{"type":"boolean","description":"Hypertension as assigned by the caller (AHA/ACC 2018 Table 4 high-risk condition). true or false. magent does not measure blood pressure."},"congestive_hf":{"type":"boolean","description":"History of congestive HF as assigned by the caller (AHA/ACC 2018 Table 4 high-risk condition). true or false. magent does not diagnose HF."},"current_smoking":{"type":"boolean","description":"Current smoking as assigned by the caller (AHA/ACC 2018 Table 4 high-risk condition). true or false. magent does not assign smoking status."},"heterozygous_fh":{"type":"boolean","description":"Heterozygous familial hypercholesterolemia as assigned by the caller (AHA/ACC 2018 Table 4 high-risk condition). true or false. magent does not diagnose FH."},"ischemic_stroke":{"type":"boolean","description":"History of ischemic stroke as assigned by the caller (AHA/ACC 2018 Table 4 major ASCVD event). true or false. magent does not diagnose stroke."},"symptomatic_pad":{"type":"boolean","description":"Symptomatic PAD as assigned by the caller from the Table 4 row (claudication with ABI <0.85, or previous revascularization or amputation). true or false. magent does not measure ABI."},"ckd_egfr_15_to_59":{"type":"boolean","description":"CKD with eGFR 15–59 mL/min/1.73 m² as assigned by the caller (AHA/ACC 2018 Table 4 printed band). true or false. magent does not compute eGFR."},"prior_cabg_or_pci_outside_major":{"type":"boolean","description":"Prior CABG or PCI outside the major ASCVD event(s) as assigned by the caller (AHA/ACC 2018 Table 4 high-risk condition). true or false. magent does not read an operative note."},"ldl_c_ge_100_on_max_statin_ezetimibe":{"type":"boolean","description":"Persistently elevated LDL-C ≥100 mg/dL (≥2.6 mmol/L) despite maximally tolerated statin and ezetimibe as assigned by the caller (AHA/ACC 2018 Table 4 high-risk condition). true or false. magent does not assay LDL-C."}}},"maxItems":25,"minItems":1}},"additionalProperties":false},"type":{"type":"string","const":"http"},"method":{"type":"string","const":"POST"},"headers":{"type":"object","additionalProperties":{"type":"string"}}},"additionalProperties":false},"output":{"type":"object","required":["type"],"properties":{"type":{"type":"string"},"example":{"type":"object"}}}}}}},"description":"AHA/ACC 2018 Table 4 very high-risk ASCVD for known clinical ASCVD. Very high-risk if ≥2 major events (recent ACS, prior MI, ischemic stroke, symptomatic PAD) or 1 major event and ≥2 high-risk conditions (age ≥65, heterozygous FH, CABG/PCI outside those events, diabetes, hypertension, CKD eGFR 15-59, current smoking, LDL-C ≥100 on max statin and ezetimibe, congestive HF). Not PCE. Not a statin, ezetimibe, or PCSK9 order. magent does not diagnose ASCVD or measure ABI or LDL-C.","lastUpdated":"2026-09-28T14:21:23.755Z","serviceName":"magent","x402Version":2}]}}